Loading organizations...
§ Private Profile · Toronto, Canada
AI-powered digital platform provides pharmaceutical market research and physician engagement for life sciences, focused on quick insights from.
KeyOps is a Toronto, Ontario, Canada-based company that provides an AI-powered digital platform for pharmaceutical market research and physician engagement in the life sciences industry. The platform enables life science companies to gather rapid insights from healthcare professionals through short online surveys and digital advisory sessions, replacing traditional in-person methods with real-time analysis, visualization tools, and self-service access via EngageAI. KeyOps serves a client base that includes Biosyent, GlaxoSmithKline, Sanofi Canada, and Becton Dickinson (BD). The company has grown to 22 employees and recently secured $4 million in seed capital. Founded in 2018 by Doulas, who has a Microsoft executive background, and Darren Anderson, with over 25 years of pharmaceutical expertise. Its business model centers on saaS platform delivering insights as a service through modular software for surveys and advisory engagements, funded via venture capital including seed rounds.
KeyOps has raised $4.0M across 1 funding round.
KeyOps has raised $4.0M in total across 1 funding round.
KeyOps has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in December 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2022 | $4M Seed | Graphite Ventures | Carol Leaman, Danny Ardellini, James Novak, Archangel Network, MaRS IAF, Starforge, Velocity Fund | Announced |
KeyOps has raised $4.0M in total across 1 funding round.
KeyOps's investors include Graphite Ventures, Carol Leaman, Danny Ardellini, James Novak, Archangel Network, MaRS IAF, StarForge, Velocity Fund.
KeyOps is a Toronto-based healthcare software startup that builds an online platform connecting pharmaceutical companies and medical device firms with physicians and key opinion leaders (KOLs) for rapid market research and insights. It serves life sciences companies like GlaxoSmithKline, Sanofi Canada, and Becton Dickinson, solving the problem of slow, costly traditional methods such as advisory boards and attitude and usage tracking (ATU) studies by enabling faster digital surveys, qualitative engagements, performance tracking, and AI-powered analysis.[1][2][4] Founded in 2020, the company has grown to 22 employees, raised $4 million in seed funding in a round led by Graphite Ventures, and expanded from Canada into the U.S. market across a dozen therapeutic areas, achieving higher response rates through targeted HCP communities and premium incentives.[1][3][4]
KeyOps was founded in 2020 by two Toronto physicians—Dr. Sam Elfassy (gastroenterologist) and Dr. Saeed Darvish-Kazem (cardiologist)—who identified the need for a more efficient way to gather insights from doctors for pharma companies.[1][4] They partnered with Doulas, a veteran Microsoft executive experienced in scaling startups, and Darren Anderson, bringing 25 years of pharmaceutical expertise, forming a team blending medical, tech, and industry knowledge.[1] Early traction came from physician founders validating usability and engagement, leading to partnerships with major clients like Biosyent and Sanofi Canada; the $4M seed round in 2023 fueled U.S. expansion and team growth.[1][3]
KeyOps rides the wave of digital transformation in healthcare market research, accelerated by demand for real-time provider insights amid regulatory shifts like expanded pharmacist scopes in Canada and AI adoption in life sciences.[1][4] Timing aligns with post-pandemic shifts to virtual engagements and pharma's need for faster KOL interactions, reducing time-to-insight from weeks to days while navigating data privacy in HCP outreach.[1][2] Market forces favoring KeyOps include growing U.S./Canada pharma spending on targeted research and AI tools for quantitative analysis; it influences the ecosystem by fostering mutually beneficial HCP-life sciences relationships, potentially extending to pharmacists and new therapeutic areas.[1][4][5]
KeyOps is poised for accelerated U.S. growth, team expansion post-seed funding, and platform enhancements like pharmacist connections amid regulatory expansions.[1][4] Trends in AI-driven pharma insights, virtual HCP communities, and personalized medicine will amplify its momentum, evolving it from a Canadian startup to a cross-border leader in Insights-as-a-Service. As life sciences prioritize data agility, KeyOps' physician-led edge positions it to redefine efficient provider engagement, delivering the quick data pharma needs in a high-stakes market.[1][2][4]